Sign In
Buy FOLD
$14.49
+0 (+0%)
At Close: Jun 03, 2026
COVID-19 driving adoption of virtual trials -
08:42am, Thursday, 04'th Jun 2020
Survey of clinical trial professionals by ERT says use of virtual approaches has risen from 33% before the coronavirus pandemic to 82%
Protalix, Chiesi edge close to potential Fabry disease approval
12:05pm, Thursday, 28'th May 2020
Israeli biotech Protalix BioTherapeutics and partner Chiesi have sent off their Biologics License Application for rare disease hopeful pegunigalsidase alfa to the FDA.
Beating Covid-19 will change how new therapies are developed - STAT
09:00am, Wednesday, 27'th May 2020
The Covid-19 pandemic is driving an unprecedented transformation of the global medical research ecosystem through the search for new therapies and vaccines.
Edited Transcript of FOLD earnings conference call or presentation 7-May-20 12:30pm GMT
06:25pm, Thursday, 21'st May 2020
Q1 2020 Amicus Therapeutics Inc Earnings Call
Billionaire Steven Cohen Bets Big on These 3 Stocks
01:47pm, Tuesday, 19'th May 2020
And they’re off to the races. All three of the major U.S. stock indexes popped on Monday after biotech company Moderna reported its experimental COVID-19 vaccine produced encouraging results in its
AVROBIO Presents New Preclinical Data on Lentiviral Gene Therapy Program for Pompe Disease at ASGCT 2020
12:00am, Thursday, 14'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
Analysts Are Updating Their Amicus Therapeutics, Inc. (NASDAQ:FOLD) Estimates After Its First-Quarter Results
01:50pm, Sunday, 10'th May 2020
It's been a good week for Amicus Therapeutics, Inc. (NASDAQ:FOLD) shareholders, because the company has just released...
Amicus Therapeutics Inc (FOLD) Q1 2020 Earnings Call Transcript
05:31pm, Saturday, 09'th May 2020
FOLD earnings call for the period ending March 31, 2020.
7 “Strong Buy” Healthcare Stocks to Buy Now
03:46pm, Friday, 08'th May 2020
As the month of May kicked off, stocks got off to a rocky start. The market slumped in response to a first quarter profit miss from eCommerce giant Amazon (NASDAQ:AMZN) and its plan to put all second-
Amicus Therapeutics Announces Virtual 2020 Annual Meeting of Shareholders
11:00am, Friday, 08'th May 2020
Amicus Therapeutics (FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that its 2020 Annual
'There is no future': the refugees who became pawns in Erdoğan’s game
06:15am, Friday, 08'th May 2020
First the asylum seekers were used to further Turkey’s regional ambitions, now they are made to suffer in quarantine camps
Edited Transcript of FOLD earnings conference call or presentation 7-May-20 12:30pm GMT
05:11am, Friday, 08'th May 2020
Q1 2020 Amicus Therapeutics Inc Earnings Call
Fairmount Funds Management LLC Buys Zogenix Inc, Amicus Therapeutics Inc, Axsome Therapeutics ...
12:00am, Friday, 08'th May 2020Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates
01:25pm, Thursday, 07'th May 2020
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -25.00% and 5.80%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
